What top creators are saying about Humacyte, Inc.(HUMA)
Biotechnology company.
6 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Humacyte, Inc. in the last 30 days yet.
Top creators covering Humacyte, Inc. (HUMA)
The 2 sources with the most insights about Humacyte, Inc. on Kazuha.
Latest insights about Humacyte, Inc. (HUMA)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Wednesday, November 12, 2025
The speaker is bearish and was shorting the stock, highlighting a significant valuation concern where the company generated only $700k in revenue with a market cap of around $250 million.
Tuesday, October 28, 2025
The speaker is bearish, mocking the company for an 'oversubscribed deal for warrants' and suggesting it's a sign of weakness.
Thursday, August 21, 2025
The CEO made a large, unscheduled sale of $3.7 million. Following the CEO's previous sales, the stock has fallen an average of 15%.
Wednesday, August 13, 2025
Monday, August 11, 2025
The speaker is extremely bearish, calling the company a 'dog' and a 'whole disaster.' This is due to extremely weak revenue ('less than a million'), with no reason seen for the stock to rebound.
Tuesday, July 29, 2025
Listed as one of the speaker's biggest losing positions, which came from a short position he was holding.
Wednesday, November 12, 2025
The speaker is bearish and was shorting the stock, highlighting a significant valuation concern where the company generated only $700k in revenue with a market cap of around $250 million.
Tuesday, October 28, 2025
The speaker is bearish, mocking the company for an 'oversubscribed deal for warrants' and suggesting it's a sign of weakness.
Thursday, August 21, 2025
The CEO made a large, unscheduled sale of $3.7 million. Following the CEO's previous sales, the stock has fallen an average of 15%.
Wednesday, August 13, 2025
Monday, August 11, 2025
The speaker is extremely bearish, calling the company a 'dog' and a 'whole disaster.' This is due to extremely weak revenue ('less than a million'), with no reason seen for the stock to rebound.
Tuesday, July 29, 2025
Listed as one of the speaker's biggest losing positions, which came from a short position he was holding.
Discussed alongside Humacyte, Inc. (HUMA)
Other assets that creators frequently mention in the same content as Humacyte, Inc..
Frequently asked
Which podcasters and creators cover Humacyte, Inc. (HUMA) the most?
The most active sources covering Humacyte, Inc. (HUMA) on Kazuha are @realmartinshkreli, @ceowatcher. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Humacyte, Inc. (HUMA) are on Kazuha?
Kazuha has indexed 6 AI-extracted insights about Humacyte, Inc. (HUMA) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Humacyte, Inc. (HUMA)?
Creators covering Humacyte, Inc. (HUMA) most frequently also discuss ABVX, QBTS, SRPT, IONQ, NVDA. See the "Discussed alongside" section above for full asset pages.